Regulatory Rumblings
The Time For Action Is NOW
Posted: Sep 6, 2019 11:00am ETToday CalMatters published an op-ed by me urging the California Legislature to make changes to the CCPA that are greatly needed.
READ MORECCPA Status Report 2: CCPA Implementation Timeline Creates Severe Compliance Pressures
Posted: Sep 4, 2019 12:00am ETOnce the California legislature adjourns on September 13, 2019, the last day for Governor Newsom to sign or veto bills passed by the legislature this session is October 13, 2019.
READ MORECCPA Status Report: Legislative Finish Line in Sight
Posted: Sep 3, 2019 12:00am ETThere are only 10 days until the California Legislative session ends on September 13th.
READ MORE"It Is Better To Be The Hammer Than The Anvil"
Posted: Aug 19, 2019 10:25am ETVarious governments here and abroad are enforcing highly restrictive new privacy laws and putting forward a broad array of privacy proposals.
READ MORE"Seller" Beware!!!
Posted: Aug 8, 2019 12:00am ETIn my last posting, I discussed the extraordinarily broad coverage of the California Consumer Privacy Act (CCPA).
READ MOREHappy New Year?
Posted: Aug 1, 2019 2:30am ETCalifornians celebrate the transition from one year to the next in unique and fun ways.
READ MOREANA Joins Opposition to HHS Prescription Drug Price Disclosure Rule
Posted: Jun 14, 2019 3:45pm ETANA has joined with Merck, Eli Lilly, and Amgen to bring a lawsuit to enjoin a HHS rule concerning prescription drugs that would otherwise blow significant holes in advertisers First Amendment protections.
READ MOREHappy Birthday GDPR
Posted: May 21, 2019 10:15am ETThis week marks the first anniversary of the European Union’s General Data Protection Regulation (GDPR). When it was launched on May 25, 2018 the GDPR was clearly the most significant privacy experiment to that point in history.
READ MOREANA Strongly Opposes New HHS Ad Disclosure Rule
Posted: May 9, 2019 11:40am ETYesterday, the Department of Health and Human Services (HHS) finalized a new rule which would require “direct-to-consumer television advertisements for prescription pharmaceuticals covered by Medicare or Medicaid to include the list price … if that price is equal to or greater than $35.” ANA strongly opposes this government requirement which is highly likely to be unconstitutional.
READ MOREMembers of the House Energy and Commerce Committee Advocate for Meaningful Federal Privacy Protections
Posted: May 8, 2019 11:40am ETThe Association of National Advertisers (ANA) has been a strong advocate calling for Congress to pass broad national data privacy legislation. All Americans, regardless of where they live, deserve the same high level of data privacy protections.
READ MORE